Page last updated: 2024-11-08

amifampridine and Autoimmune Disease

amifampridine has been researched along with Autoimmune Disease in 1 studies

Amifampridine: 4-Aminopyridine derivative that acts as a POTASSIUM CHANNEL blocker to increase release of ACETYLCHOLINE from nerve terminals. It is used in the treatment of CONGENITAL MYASTHENIC SYNDROMES.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lundh, H1
Nilsson, O1
Rosén, I1

Other Studies

1 other study available for amifampridine and Autoimmune Disease

ArticleYear
Treatment of Lambert-Eaton syndrome: 3,4-diaminopyridine and pyridostigmine.
    Neurology, 1984, Volume: 34, Issue:10

    Topics: 4-Aminopyridine; Aged; Amifampridine; Aminopyridines; Autoimmune Diseases; Female; Humans; Middle Ag

1984